all report title image

SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET ANALYSIS

Smoking Cessation and Nicotine De-addiction Products Market, By Route of Administration (Oral, Transdermal, Nasal , Sublingual), By Product (Nicotine Replacement Therapy, Nicotine Spray, Nicotine Inhalers, Nicotine Gum, Nicotine Transdermal Patches, Nicotine Sublingual Tablets, Nicotine Lozenges, Drug Therapy, Varenicline, Zyban, Nicorette Buccal, E-cigarettes/E-liquid), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Jul 2024
  • Code : CMI134
  • Pages :358
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Smoking Cessation and Nicotine De-addiction Products Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
  • GlaxoSmithKline plc (GSK)
  • Pfizer Inc.
  • Johnson & Johnson
  • Novartis International AG
  • Imperial Brands plc
  • British American Tobacco plc (BAT)
  • Cipla Inc.
  • McNeil AB
  • NJOY, Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Perrigo Company plc
  • Fertin Pharma
  • Philip Morris International Inc.
  • Alkalon A/S
  • Japan Tobacco Inc.
  • Nicotek, LLC
  • 22nd Century Group Inc.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.